
About one in four listings failed to complete in 2026, while at least 78 companies delayed or dropped plans.
About one in four Hong Kong listing deals failed to complete in 2026, the highest share since 2008, according to Bloomberg-compiled data. At least 78 companies have postponed, withdrawn or allowed listing plans to lapse since the start of the year.
The pullbacks come despite Hong Kong IPOs raising more than US$50 billion in 2026, only the third time proceeds have passed that level. Deal activity has eased over the past three months as investors grew more cautious about AI investments, shares struggled and regulators increased scrutiny.
Companies completed 17 Hong Kong listings in August-October, the fewest in a three-month period since February-April 2025. Some deals have been scaled back or delayed: Suzhou Dongshan Precision Manufacturing raised less than half the amount it had previously sought, while Baidu AI chip unit Kunlunxin’s potential US$2 billion IPO may slip into next year, according to people familiar with the matter.
The Hang Seng Index has fallen 8.2% this year, with concerns about higher technology financing costs and Beijing’s policy support weighing on the market. Hong Kong’s exchange also extended the validity of IPO applications to 12 months from six in August, allowing companies more time to delay without refiling.
Regulatory scrutiny has intensified, including warnings against practices that could artificially inflate demand. Richard Wang, a Freshfields partner, said more than 100 mainland-listed companies had applied or announced plans to list in Hong Kong over the past 18 months, adding to pressure on the pipeline.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.